Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

21 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Thalomid Articles

Celgene Designs New Series Of Anti-Inflammatories

4 September 1995

Adrulis' Thalidomide In Cytokine Test

14 August 1995

Celgene's thalidomide gets orphan status for mouth ulcers

12 June 1995

EMEA Fee Decision Expected This Week

23 January 1995

Celgene Starts Studies

2 January 1995

THALIDOMIDE TRIALS IN HIV

2 May 1994

REVIEW OF THALIDOMIDE AGREEMENT

28 March 1994

CELGENE TO FILE FOR THALIDOMIDE IN AIDS

10 January 1994

THALIDOMIDE PROMISEIN HIV TREATMENT

19 July 1993

PHARMA DIRECTION FOR BRITISH BIO-TECHNOLOGY

19 July 1993

SHAPING THE IMAGE OF THE PHARMA INDUSTRY

22 March 1993

THE UK DRUG INDUSTRYIN REVIEW: 1961-1991

4 May 1992

THAMIDOMIDE AS AN IMMUNOSUPPRESSANT

27 April 1992

CHIROS ACQUIRES ENZYMATIX' CHIRAL DIV

6 April 1992

CHIROS ACQUIRES ENZYMATIX' CHIRAL DIV

6 April 1992

Showing 101-115 of 115 articles

Go to beginningPrevious
  • 1
  • 2
NextGo to end
  • Hot Topics
  • Most Read
  • Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
  • Elan makes "transformational" acquisitions and a divestment
  • HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
  • Is failure to adopt business process management putting the pharma industry at risk?
  • Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
  • Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
  • Elan makes "transformational" acquisitions and a divestment
  • HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
  • Is failure to adopt business process management putting the pharma industry at risk?
  • Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS